Publications
2025
Hervé Bonnefoi, Florence Lerebours , Marina Pulido, Monica Arnedos, Olivier Tredan, Florence Dalenc, Séverine Guiu, Luis Teixeira, Delphine Mollon, Christelle Levy, Benjamin Verret, Heba Dawood, Laura Deiana, Marie-Ange Mouret Reynier, Paule Augereau, Jean-Luc Canon , Noémie Huchet, Clara Guyonneau , Jérôme Lemonnier, Gaetan MacGrogan, Anthony Gonçalves , Elodie Darbo , Richard Iggo. Darolutamide or capecitabine in triple-negative, androgen receptor-positive, advanced breast cancer (UCBG 3-06 START): a multicentre, non-comparative, randomised, phase 2 trial. Lancet Oncol. 2025 Mar; 26(3):355-366.
Clement Larrue, Sarah Mouche, Jerome Tamburini. The E3 ubiquitin ligase MARCH5 promotes mitochondrial fusion and cell-cycle progression in acute myeloid leukemia. Blood Adv. 2025 Jan 28;9(2):337-342.
2024
Adama Sidibé, Vasyl V Mykuliak, Pingfeng Zhang, Vesa P Hytönen, Jinhua Wu, Bernhard Wehrle-Haller. Acetyl-NPKY of integrin-β1 binds KINDLIN2 to control endothelial cell proliferation and junctional integrity. iScience. 2024 May 28;27(6):110129.
Clement Larrue, Sarah Mouche, Paolo Angelino, Maxime Sajot, Rudy Birsen, Olivier Kosmider, Thomas Mckee, François Vergez, Christian Recher, Véronique Mansat-De Mas, Qiong Gu, Jun Xu, Petros Tsantoulis, Jean-Emmanuel Sarry, Jerome Tamburini. Targeting ferritinophagy impairs quiescent cancer stem cells in acute myeloid leukemia in vitro and in vivo models. Sci Transl Med. 2024 Jul 24;16(757): eadk1731.